Creative Proteomics Metabolomics Expands Service Offering with the Launch of Gut Microbiota Metabolomics Solution

Exosome Research—Impeding into an Epoch of Bursting Development

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.

CD BioGlyco Developed Various Strategies for Sialic Acid Analysis

Creative Biostructure Provides iEM Platform for Viral Research

MicrobioSeq’s Plasmid Identification Service Boosts Microbial Characterization Research

CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research

CD Genomics Introduces Professional and Mature Long Amplicon Analysis Service

Huateng Pharma Supplies CAS NO.864731-61-3 in Large Quantities

About Huateng Pharma Huateng Pharma is a leading and professional manufacturer which can provide APIs, pharmaceutical intermediates, PEG derivatives, biochemical reagents, Vitamin D Derivatives and so on. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

iVexSol Closes $23.8M Series A-3 Financing; Funds to Revolutionize the Production of Lentiviral Vectors

Kroger Health Establishes Clinical Trial Site Network to Increase Reach and Access to Research Studies

Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial

Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference

Beacon Biosignals CEO Jacob Donoghue to Speak On Panel at Precision Medicine World Conference

Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials

Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials

Bellin Health Drives Increase in Online Self-Scheduling Appointments with Launch of New Patient Access Experience from Kyruus

Kyruus today announced that integrated healthcare delivery system, Bellin Health, recently selected Kyruus to support a new digital patient access experience on its website.

Linus Health Earns Numerous Awards as Digital Health Pioneer in Alzheimer’s and Other Dementia

Recent accolades honoring the company’s technology and workplace reflect its growing industry impact

AVIA Announces Nationwide Launch of its Digital Health Marketplace

AVIA just announced the launch of AVIA Marketplace, a vendor selection platform available for free. It provides a one-stop shop for hospital and health systems executives to research and select digital health solutions for their transformation journey.

Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina

Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina

CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients

CureSearch for Children's Cancer is collaborating with Children's Oncology Group (COG), Labcorp Drug Development, Pfizer, UTHealth Houston School of Public Health, and Thermo Fisher Scientific on a new study to examine the economic and treatment benefits of molecular testing for childhood cancer patients.

Orbita Launches Solution to Transform Healthcare Website Search Functionality

Orbita, a leading provider of intelligent virtual assistants and workflow automation for healthcare, launched a new solution set to transform the healthcare website experience. Orbita Blaze uses conversational AI and advanced search technology to interpret and address patients’ requests promptly and with precision, so they access the information and care they need.

VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions

The Bill & Melinda Gates Foundation awarded VisualDx a new grant to develop diagnostic tools for surveillance, detection, and triage of Neglected Tropical Diseases (NTDs) and other rare infectious diseases in India and Nigeria. This project comes on the heels of similar public health collaborations with HHS and the state of Vermont. It also marks the second Gates Foundation grant VisualDx has received, following a successful 2020 project in Botswana to provide an offline version of its clinical decision support tool for users in remote areas.